anti-counterfeiting
Counterfeit Drugs – Where There’s a Profit, There’s a Way!
April 11 by Ashley SmithThe counterfeit drug business makes money – an awful lot of money. After all, it’s easier to make a convincing fake pill than a pair of designer jeans and the potential mark-up is far hi...
Boehringer Ingelheim's Johannes Schoen on How to Prepare for the Falsified Medicines Directive
February 18 by Pharmaceuticals & Biotechnology EditorIn this recent interview, Johannes Schoen, Supply Network Quality Management Anti-Counterfeitng, Boehringer Ingelheim speaks to Andrea Charles from Pharma IQ, following facilitating the "Anti-Counterf...
Smartphone Use and Healthcare: How do Smartphones Impact Healthcare Professionals and Influence the Way They Practice?
November 28 by Pharmaceuticals & Biotechnology EditorEPG asked 260 healthcare professionals in the EU & US quations about their use of mobile devices. This infographic compares 2010-2012 and EU v US. To find out the results, download no...
How Can We Still Deliver an Effective Anti-Counterfeiting Program When Facing Cost Restraints?
January 26 by Pharma IQCases of counterfeit pharmaceuticals being discovered entering the United States are on the up.Up 200 percent to $11 million (£7 million) in 2011 to be precise, based on the domestic value of seizures...
Serialisation, Traceability and Coding – Responding as a Pharmaceutical Company to the Challenges
October 10 by Pharmaceuticals & Biotechnology EditorIn this presentation Christoph Krähenbühl, IS Programme Manager, Pack Coding and Product Security, AstraZeneca discusses Product security, patient safety, anti-counterfeiting and...
Top Pharmaceutical Manufacturer Selects Systech to Meet Brazil’s Anti-Counterfeiting Regulatory Requirements
May 24 by Pharma IQ NewsCranbury, New Jersey, May 24, 2011- Systech International, innovator of Packaging Execution Systems (PES), and our Brazilian Partner Videojet today announced that one of the world’s largest pharmaceut...
Don’t Get Lost in Translation – Reflections on Pharmaceutical Labelling
May 07 by Helen WinsorMark Gibson, Consumer Information Specialist at Gibson Research Consultancy, joins Helen Winsor form Pharma IQ, to discuss packaging and labelling in the healthcare industry. In this exclusive intervi...
The Dark Side of Globalisation: Conquering Counterfeit Medicine Now Requires a Global Solution
April 04 by Amber ScorahPart of the impact of the globalisation of the pharmaceutical industry has been an increase in the volume of counterfeiting and the level of sophistication. In this podcast Jeffrey Gren, Director of...
The True Cost of Not Having Brand Protection
February 16 by Pharma IQWith the performance of new and existing IPs potentially being the difference between success and failure in the modern business world, it is arguably more important than ever that these are protected...
Changes and Challenges in the International Counterfeit Landscape
January 17 by Helen WinsorDirk Schaub, IP Crime Investigator at Germany Customs, joins Pharma IQ to discuss challenges and recent developments in anti-counterfeiting. To listen to the podcast now go to German Customs &n...
German Customs – Cracking Down on Pharma Counterfeiting
December 20 by Pharma IQDirk Schaub, IP Crime Investigator at Germany Customs, joins Helen Winsor from Pharma IQ, to discuss challenges and recent developments in anti-counterfeiting. He highlights the main threats facing...
5 Things You Should Know about Pharmaceutical Anti-Counterfeiting
December 13 by Helen WinsorSébastien Mauel, Head of Product Security at Ares Trading SA, an affiliate of Merck Serono SA, joins Pharma IQ to discuss anti-counterfeiting. Pharma IQ: How severe would you say the counterfeiting s...